Nontyphoid Salmonella infection in heart transplant recipients
Abstract
BACKGROUND: There are only a few reported series of nontyphoid Salmonella infection in renal transplant recipients. Data are scarce in heart transplant recipients. This article described our experience with nontyphoid Salmonella infection in heart transplant recipients and reviewed the literature.
METHODS: Retrospective chart review. Data were compared with previously reported series in renal transplant recipients.
RESULTS: Of the 265 patients undergoing heart transplantation from 1987 to 2005, 4 patients (1.5%) had infection caused by nontyphoid Salmonella. All patients were male, aged ranging from 2 to 62 years. None of them had a history of acute rejection before the occurrence of Salmonella infection. The time interval between transplantation and the Salmonella infection ranged from 0 day to 17 months. Gastrointestinal salmonellosis occurred in 1 patient and bloodstream infection in 3 patients. Intravenous ceftriaxone was given in 3 bacteremic patients. One patient died after 6 days of septic shock. For nontyphoid Salmonella serogroups, 2 cases were group D and 2 cases were group C. Ciprofloxacin resistance was present in 1 of 4 Salmonella isolates. There was no recurrence in 3 survivors. Compared with previous reported cases in renal transplantation, patients with heart transplantation had low rates of urinary tract infection and recurrence. The mortality rate was 25% in heart transplant recipients.
CONCLUSIONS: Nontyphoid Salmonella infection in heart transplant…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 265 participants or records.
Read the paper
Related studies
- Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes
- Mutation supply and relative fitness shape the genotypes of ciprofloxacin-resistant Escherichia coli
- Genomic Survey of E. coli From the Bladders of Women With and Without Lower Urinary Tract Symptoms
- Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017–18
- Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli
- Emerging evidence-based innovative approaches to control catheter-associated urinary tract infection: a review
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.